ONCT Oncternal Therapeutics

Watchlist

Close Apr 26 16:00 ET

24.54MMarket Cap-617P/E (TTM)

Oncternal Therapeutics Stock Analyst Ratings & Price Target

Updated: Apr 15, 2024

Based on 3 analysts giving stock ratings to Oncternal Therapeutics in the past 3 months

Buy

Updated: Apr 15, 2024

The average Oncternal Therapeutics stock price target is 26.50 with a max estimate of 28.00 and a min estimate of 25.00

Review Oncternal Therapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 15, 2024

Buy

Updated: Apr 15, 2024

Overall